Market News AIOpen the app

BDX stock news · Becton, Dickinson and Company

Stories about Becton, Dickinson and Company (BDX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for BDX

Follow Becton, Dickinson and Company (BDX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BDX
Free on the App Store and Google Play, or on the web.
  1. Nov 3, 2026, 6:48 AM ET · Market

    BD made the list of the top 100 best companies to work for in Southeast Asia for 2026.

    Neutral

    Becton, Dickinson and Company joined the 2026 Fortune workplace list for Southeast Asia. The recognition does not report a change to BDX's business outlook.

  2. Oct 5, 2026, 6:38 AM ET · Results

    Becton Dickinson shares the full details from their earnings call for the third quarter of 2026.

    Good for BDX

    BDX reported sales growth across most of its business and raised its full-year profit forecast. Pressures in a small part of the business do not outweigh the stronger results.

  3. Aug 19, 2026, 1:36 PM ET · Market

    Wednesday's Developments Surrounding Becton Dickinson Stock.

    Neutral

    Becton Dickinson's stock rose despite the FDA's recall announcement, indicating a potential sector rotation. However, the recall of sodium chloride ampules poses risks to patient safety and could lead to operational challenges for the company.

  4. Aug 13, 2026, 2:05 PM ET · Product

    Contamination issues in recalled Becton Dickinson products affect Medline's convenience kits.

    Bad for BDX

    The FDA's alert about contamination in Medline's convenience kits, linked to a recall of Becton Dickinson products, poses significant risks to both companies. Medline must manage the fallout from the contamination and ensure patient safety, while Becton Dickinson faces potential regulatory scrutiny and reputational damage due to the recall.

  5. Aug 6, 2026, 12:01 PM ET · Market

    Becton Dickinson Raises Profit Forecast, Indicating Robust Growth Trajectory.

    Good for BDX

    Becton Dickinson reported better-than-expected earnings and raised its profit outlook, driven by strong performance across its medical technology divisions. This positive news reflects the company's ability to navigate challenges and capitalize on market opportunities, likely leading to increased investor confidence and stock performance.